Image
|
Figure Caption
Fig. 3 In vitro percent cell viability of LNCaP and PC-3 cells treated with docetaxel- and brusatol-loaded PSMA-targeted nanoparticles and controls at different concentrations (a) LNCaP cells (24 hours), (b) PC-3 cells (24 hours), (c) LNCaP cells (72 hours), (d) PC-3 cells (72 hours). Data are mean ± SD (n=4).
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Biomed. Pharmacother.